Weekly Poll#4: The cost of capital for early‐stage Biotech (cash multiples realised)
Quality sites
- Migliori Casino Online
- Online Casinos UK
- Casino Non Aams
- Casinos Not On Gamstop
- UK Casinos Not On Gamstop
- Best UK Casinos Not On Gamstop
- Casino Sites Not On Gamstop
- Meilleur Casino En Ligne Live
- Casino Sites Not On Gamstop
- Casino Sites Not On Gamstop
- Non Gamstop Casino Sites UK
- Non Gamstop Casinos
- Best Online Casino Canada
- Casino Sites Not On Gamstop
- Non Gamstop Casino UK
- UK Online Casinos Not On Gamstop
- Best Slot Sites 2025
- Casinos Not On Gamstop
- Meilleur Casino En Ligne
- Non Gamstop Casinos
- Slots Not On Gamstop
- Non Gamstop Casino
- New Online Casinos Not Registered With Gamstop
- Casino Non Aams Sicuri
- Casino Sites UK Not On Gamstop
- Casino Non Aams Italia
- Bitcoin Casino
- Meilleur Site Casino En Ligne Belgique
- Casino App
- Migliori Siti Scommesse Non Aams
- Meilleur Casino En Ligne De France
- Plinko Game Avis
- Meilleur Site De Paris Sportifs
- Nouveau Jeu Casino En Ligne
- Siti Non Aams
- No Kyc Online Casino
- Casino Italia Non Aams
- 메이저사이트
- Meilleur Casino En Ligne 2026
- Siti Casino Non AAMS
- Giochi Senza AAMS
This is the fourth of 4 weekly Polls hosted throughout July that will accompany the August edition of Drugs&Dealers Magazine ‘Lost in Translation: Tech Transfer and Start-up Capital’.
This poll reviews the cash multiples realised by bioscience investors on their most recent investments.
The results from this Poll will be published exclusively within the weekly Subscriber newsletter and analysed within the August issue of Drugs&Dealers. Thanks for voting.
If you are interested in learning what options are open to biotechs and spin outs in terms of early stage and follow-on funding, plus how these are viewed by the community as a whole, you should consider attending our ‘Biotechs and the City - Tech Transfer and Start-up Capital’ evening panel and networking reception on the 4th September.

Leave a comment